AirSculpt Technologies, Inc. (AIRS)
NASDAQ: AIRS · Real-Time Price · USD
6.29
-0.16 (-2.48%)
At close: Jul 24, 2025, 4:00 PM
6.40
+0.11 (1.75%)
After-hours: Jul 24, 2025, 7:55 PM EDT

Company Description

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.

It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool.

In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas.

Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure.

Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.

AirSculpt Technologies, Inc.
AirSculpt Technologies logo
CountryUnited States
Founded2012
IPO DateOct 29, 2021
IndustryMedical Care Facilities
SectorHealthcare
Employees422
CEOYogesh Jashnani

Contact Details

Address:
1111 Lincoln Road, Suite 802
Miami Beach, Florida 33139
United States
Phone786 709 9690
Websiteairsculpt.com

Stock Details

Ticker SymbolAIRS
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$11.00
CIK Code0001870940
CUSIP Number009496100
ISIN NumberUS0094961002
Employer ID87-1471855
SIC Code8011

Key Executives

NamePosition
Yogesh JashnaniChief Executive Officer and Director
Dr. Aaron J. Rollins M.D.Founder and Executive Chairman
Dennis Dean CPAChief Financial Officer
Philip BodieChief Accounting Officer
Stephanie Evans GreeneChief Marketing Officer

Latest SEC Filings

DateTypeTitle
Jun 11, 20258-KCurrent Report
Jun 11, 2025424B5Filing
Jun 9, 2025424B5Filing
May 13, 2025SCHEDULE 13G/AFiling
May 8, 20258-KCurrent Report
May 2, 202510-QQuarterly Report
May 2, 20258-KCurrent Report
Mar 28, 2025ARSFiling
Mar 28, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 28, 2025DEF 14AOther definitive proxy statements